Summary
This business focuses on transforming the manufacturing of cell therapies through innovative microfluidic technology. Their flagship product, the Infinity MTx platform, is designed for research and process development, enabling high yields and rapid genome editing while maintaining cell health. The company aims to address scalability and cost challenges in cell therapy production, making advanced treatments more accessible to patients worldwide.
Based on content on cellfebiotech.com
No similar companies found
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
6.1 years — Since Dec 2018
Web Hosting
Platform
E-Mail Provider
Microsoft Office 365, Proofpoint
NAICS Code
325414
SIC 4 Digit Code
2836
SIC 2 Digit Code
28
Industry
1. Biotechnology and Cell Therapy Manufacturing
2. Biological Product (except Diagnostic) Manufacturing
Vendor
Source
Microsoft
TXT Record
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|